To more thoroughly study the role of endogeneous ADRBK1 in pancreatic cancer cells, two cell lines with moderate (PaTu 8988t) and high (S2-028) mRNA expression were subjected to siRNA-mediated transient inhibition of ADRBK1 expression. The gene discussed is GRK2; the disease is pancreatic neoplasm.